Fundz

OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer

PRIVATEFeb 15, 2024

Position

Chief Medical Officer

Company

OnKure Therapeutics

Samuel Agresta
sagresta@onkure.com
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma

Description

OnKure, Inc. announces the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer.

Quick answer

OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer (February 15, 2024). OnKure Therapeutics is based in Boulder, Colorado, United States.

Who is the new Chief Medical Officer at OnKure Therapeutics?
OnKure Therapeutics named Samuel Agresta Chief Medical Officer, announced February 15, 2024.
What did OnKure Therapeutics announce on February 15, 2024?
OnKure, Inc. announces the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer.
What does OnKure Therapeutics do?
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated...
Where is OnKure Therapeutics based?
OnKure Therapeutics is based in Boulder, Colorado, United States.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (February 20, 2024), Terns Pharmaceuticals (February 7, 2024), Corvus Pharmaceuticals, Inc. (February 6, 2024) and Madrigal Pharmaceuticals (February 28, 2024) also announced leadership changes within 45 days of OnKure Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at OnKure Therapeutics, and when

A new leader at OnKure Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OnKure Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OnKure Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OnKure Therapeutics

Location

6707 WINCHESTER CIRCLE

Boulder, Colorado, United States

About

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated pharmacological pathways, with a focus on oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OnKure Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Samuel
Likely contact at this company
••••••••@••••••••

See Samuel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OnKure Therapeutics's next move

Learn about Strategic plan

OnKure Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.